Skip to main content

Losartan Potassium and Hydrochlorothiazide

NDC 42291-502 · AvKARE

Generic namelosartan potassium and hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE
Strength12.5; 50 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

42291-502-10 — 1000 TABLET, FILM COATED in 1 BOTTLE (42291-502-10)

42291-502-90 — 90 TABLET, FILM COATED in 1 BOTTLE (42291-502-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

33342-283 — amlodipine,valsartan and hydrochlorothiazide, 33342-284 — amlodipine,valsartan and hydrochlorothiazide, 33342-285 — amlodipine,valsartan and hydrochlorothiazide, 33342-286 — amlodipine,valsartan and hydrochlorothiazide, 33342-287 — amlodipine,valsartan and hydrochlorothiazide, 33342-467 — Triamterene and Hydrochlorothiazide, 35356-807 — hydrochlorothiazide, 42291-462 — Telmisartan and Hydrochlorothiazide, 42291-463 — Telmisartan and Hydrochlorothiazide, 42291-464 — Telmisartan and Hydrochlorothiazide, 42291-503 — losartan potassium and hydrochlorothiazide, 42291-504 — losartan potassium and hydrochlorothiazide, 42291-924 — olmesartan medoxomil-hydrochlorothiazide, 42291-925 — olmesartan medoxomil-hydrochlorothiazide, 42291-926 — olmesartan medoxomil-hydrochlorothiazide, 42291-965 — Valsartan and Hydrochlorothiazide, 42291-966 — Valsartan and Hydrochlorothiazide, 42291-967 — Valsartan and Hydrochlorothiazide, 42291-968 — Valsartan and Hydrochlorothiazide, 42291-969 — Valsartan and Hydrochlorothiazide, +1060 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels